Prevalence of primary hyperaldosteronism in moderate to severe hypertension in the Central Europe region

Journal of Human Hypertension

Volumn 17, Issue 5, 2003, Pages 349-352

  Strauch B ^a   Zelinka, T ^a   Hampf, M ^b   Bernhardt, R ^c   Widimsky Jr , J ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c SAARLAND UNIVERSITY   (Germany)

Author keywords

Aldosterone renin ratio; Prevalence; Primary aldosteronism

Indexed keywords

ALDOSTERONE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIHYPERTENSIVE AGENT; POTASSIUM; RENIN;

ADENOMA; ADRENALECTOMY; ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; CZECH REPUBLIC; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; EUROPE; FAMILIAL DISEASE; FEMALE; HOSPITALIZATION; HUMAN; HYPERCORTISOLISM; HYPERPLASIA; HYPERTENSION; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; MALE; PATIENT REFERRAL; PHEOCHROMOCYTOMA; PLASMA RENIN ACTIVITY; POTASSIUM BLOOD LEVEL; PREVALENCE; PRIMARY HYPERALDOSTERONISM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENOVASCULAR HYPERTENSION;

ADULT; CZECH REPUBLIC; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERALDOSTERONISM; HYPERTENSION; MALE; MIDDLE AGED; PREVALENCE; SEVERITY OF ILLNESS INDEX;

EID: 0037500115     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001554     Document Type: Article

References (15)

1. Conn JW. Primary aldosteronism, a new clinical syndrome. J Lab Clin Med 1955; 45: 16-17.
2. Conn JW. The evolution of primary aldosteronism 1954-1967. Harvey Lect 1968; 62: 257-291.
3. Hiramatsu et al. A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Arch Intern Med 1981; 141: 1589-1593.
4. Fardella C et al. Primary hyperaldosteronism in essential hypertensives: Prevalence, biochemical profile and molecular biology. J Clin Endocrinol Metab 2000; 85: 1863-1867.
5. Loh K et al. Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. J Clin Endocrinol Metab 2000; 85: 2854-2859.
6. Lim PO et al. High prevalence of primary aldosteronism in the Tayside hypertension clinic population. J Hum Hypertens 2000; 14: 311-315.
7. Stowasser M. Primary aldosteronism: Rare bird or common cause of secondary hypertension? Curr Hypertens Rep 2001; 3: 230-239.
8. Gordon RD, Stowasser M. Primary aldosteronism: Are we diagnosing and operating on too few patients? World J Surg 2001; 25: 941-947.
9. Kaplan NM. Cautious over the current epidemic of primary aldosteronism. Lancet. London 2001; 357: 953-954.
10. Ganguly A. Primary aldosteronism. N Engl J Med 1998; 339: 1828-1834.
11. Peters J et al. Molekular-biologie. Klinik und therapie steroidbedingter hypertonien. In: Ganten D, Ruckpaul K (eds). Handbuch der Molekularen Medizin. Springer-Verlag: Berlin, 1998, pp 413-452.
12. Seeman T, Widimsky J, Hampf M, Bernhardt R. Abolished nocturnal blood pressure fall in a boy with glucocorticoid-remediable aldosteronism. J Hum Hypertens. 1999; 13: 823-828.
13. Magill SB et al. Comparison of adrenal venous sampling and computed tomography in the differentiation of primary aldosteronism. J Clin Endocrinol Metab. 2001; 86: 1067-1071.
14. Gordon RD, Stowasser M, Klemm SA, Tunny TJ. Primary aldosteronism and other forms of mineralocorticoid hypertension. In: Swales JD (ed). Textbook of Hypertension. Blackwell Scientific Publications: London, 1994, pp 865-892.
15. Gordon RD et al. Evidence that primary aldosteronism may not be uncommon: 12% incidence among anti-hypertensive drug trail volunteers. Clin Exp Pharmacol Physiol 1993; 20: 296-298.